Actively Recruiting
Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer
Led by Helse Stavanger HF · Updated on 2026-04-30
1200
Participants Needed
1
Research Sites
1252 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
* A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer * Prospective collection of tissues to explore potential biomarkers in blood and/or primary or secondary cancers and/or normal colon
CONDITIONS
Official Title
Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of colorectal cancer, primary or metastatic (liver), with a treatment intention of planned curative surgery
- Informed consent to participate
- Age 18
You will not qualify if you...
- Failure to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stavanger University Hospital
Stavanger, Norway, 4068
Actively Recruiting
Research Team
R
Ramesh L. Kajavi, RN
CONTACT
M
Marina Alexeeva, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here